| Literature DB >> 31101421 |
Eun-Ju Ko1, Youri Lee2, Young-Tae Lee2, Yu-Jin Jung3, Vu L Ngo4, Min-Chul Kim5, Ki-Hye Kim2, Bao-Zhong Wang6, Andrew T Gewirtz7, Sang-Moo Kang8.
Abstract
Incorporation of membrane-anchored flagellin molecules into the surfaces of influenza virus-like particles (VLP) was previously reported to promote T helper (Th) 1-biased IgG antibody production and protective efficacy of co-presented vaccine antigens. Herein, we investigated the potential adjuvant effects and mechanisms of flagellin-expressing VLP (FliC-VLP) as an independent component on influenza vaccination in wild-type and mutant mouse models. FliC-VLP adjuvanted influenza vaccination was highly effective in promoting the induction of Th1-biased IgG isotype switched antibodies, enhanced protection, and long-lasting IgG antibody responses in both wild-type and CD4-knockout mice. In contrast, the adjuvant effects of soluble flagellin were Th2-biased and required CD4 T helper cells. The adjuvant effects of FliC-VLP were less dependent on CD4 T cells and flagellin-mediated innate immune signaling pathways. The results suggest that FliC-VLP might play an effective adjuvant role in an immune competent condition as well as in a defect of CD4 T cells.Entities:
Keywords: Adjuvant; CD4 T cells; Flagellin; Influenza; VLP
Year: 2019 PMID: 31101421 PMCID: PMC7274143 DOI: 10.1016/j.vaccine.2019.05.018
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641